More Fields

Filters

Profiles which have:

Recent Changes

Profiles with recent changes to:
Sign up to Download

1-30 of 31 results

  • www.bach.attorney
  • 1
  • 1
Our office has grown mostly through referrals. We've been able to earn the trust of our clients and they share that trust with their family, friends, and associates. We're looking forward to earning that trust with you... We're a boutique Law Office..
Relevance: 84.687614
  • www.connect2bms.com
At Bristol Myers Squibb, we're committed to supporting our customers through dedicated Account teams and patient-focused educational resources designed for payers, organized customers, formulary decision-makers, and professionals involved in..
Relevance: 83.6935
  • www.bmsmedicaleducation.com
  • 2
Your use of this information is subject to the terms and conditions of our Legal Notice and Privacy Policy. This site is intended for healthcare professionals and is for informational purposes only...
Relevance: 78.46738
  • www.myelomacentral.com
Myeloma Central is your hub for basic information about multiple myeloma. Our goal is to connect people affected by multiple myeloma with helpful information and resources... Learn about Myeloma Central-created to connect people affected by multiple..
Relevance: 50.150043
  • www.bmsanticoagulantanalyzer.net
  • 1
  • 1
The Anticoagulant Treatment Analyzer is an interactive, customizable tool that uses administrative healthcare claims data OR electronic health record data to describe the demographic characteristics, clinical characteristics and treatment patterns..
Relevance: 50.150043
  • www.bmsremspatientsafety.com
To avoid embryo-fetal exposure, Risk Evaluation and Mitigation Strategy (REMS) programs are mandatory for the REMS products THALOMID® (thalidomide), POMALYST® (pomalidomide), REVLIMID® (lenalidomide) and generic lenalidomide. The THALOMID REMS®..
Relevance: 50.150043
  • www.car-t-academy.com
Learn about the role of bridging therapy, its coordination and delivery, and various bridging therapy options; the purpose of lymphodepleting (LD) chemotherapy and its impact on the immune system; the LD regimens used in CAR T cell trials; the..
Relevance: 49.361
  • news.bms.com
  • 3
  • 3
Bristol-Myers Squibb Company (NYSE: BMY) today announced that it has completed the previously announced planned acquisition of Padlock Therapeutics, Inc. The transaction includes full rights to Padlock's Protein/Peptidyl Arginine Deiminase inhibitor..
Relevance: 49.361
  • www.reblozylpro.com
REBLOZYL offers 3 dose levels to optimize patient response. Learn how to titrate REBLOZYL to maximize clinical benefit... Learn more about how Reblozyl® can help patients with anemia due to MDS-RS or patients with beta thalassemia who require..
Relevance: 49.361
  • www.realconnections.com
  • 1
  • 1
REAL Connections is a simple communication program to help engage cancer patients... The REAL Connections program provides practical, evidence-based tools for care teams and patients with cancer... Aims to optimize current education efforts through..
Relevance: 48.800735
  • www.onuregpro.com
Cheson BD, Bennett JM, Kopecky KJ, et al. Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia. J..
Relevance: 48.800735
  • www.connectregistries.com
The Connect® Registry Team would like to thank all the patients and their caregivers who have contributed so far to the Connect® Registries. Because of you, we have been able to collect information on Myeloid diseases and Multiple Myeloma (MM)...
Relevance: 48.800735
  • www.opd.bmssafetytools.com
For safety information about OPDIVO® (nivolumab) or OPDIVO® in combination with YERVOY® (ipilimumab), please refer to the Local Prescribing Information which can found in the Product Pack...
Relevance: 48.800735
  • www.targetedproteindegraders.com
BMS is leading in targeted protein degradation by taking two approaches: ligase modulation and ligand-directed degradation... Both strategies degrade proteins that contribute to disease progression. 1-6 The exact effect of each cereblon E3 ligase.....
Relevance: 48.53228
  • www.evotazhcp.com
EVOTAZ and REYATAZ are registered trademarks of Bristol-Myers Squibb Company. All other trademarks are the property of their respective owners and not of Bristol-Myers Squibb Company... Learn about EVOTAZ® (atazanavir/cobicistat) for treatment-naïve..
Relevance: 48.53228
  • www.sprycel-hcp.com
SPRYCEL is associated with the following warnings and precautions: myelosuppression, bleeding-related events, fluid retention, cardiovascular toxicity, pulmonary arterial hypertension, QT prolongation, severe dermatologic reactions, tumor lysis..
Relevance: 48.53228
  • www.cobenfyhcp.com
Anticholinergic Adverse Reactions in Patients with Renal Impairment: Trospium chloride, a component of COBENFY, is substantially excreted by the kidney. COBENFY is not recommended in patients with moderate or severe renal impairment (estimated..
Relevance: 48.53228
  • bmspatientresources.com
  • 1
We are a global biopharmaceutical company focused on helping to address the unmet medical needs of patients with serious diseases. In 2020, we invested $11.1 billion in R&D, which included the discovery and development of new medicines...
Relevance: 48.203823
  • www.learnabouttyk2.com
  • 1
At BMS, we are committed to helping patients prevail over serious immune-related diseases such as psoriasis. We're excited about our innovative research on the TYK2 pathway and the role it may play in immunology... Learn more about the tyrosine..
Relevance: 48.203823
Relevance: 43.7511
Relevance: 43.228706
Relevance: 43.228706
Relevance: 39.2862
Relevance: 38.57564
  • www.activatethecard.com
A secure, web-based process for you to help eligible patients activate a Co-Pay Card...
Relevance: 38.57564
  • www.bms.com
  • 3
  • 6
  • 36
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases...
Relevance: 35.49551
  • www.connect2bms.com
At Bristol Myers Squibb, we're committed to supporting our customers through dedicated Account teams and patient-focused educational resources designed for payers, organized customers, formulary decision-makers, and professionals involved in..
Relevance: 35.28959
  • www.detect-afib.com
  • 1
AFib may be difficult to detect in some patients, such as those with asymptomatic or paroxysmal AFib. In addition to assessing patients in-office via electrocardiogram (ECG), remote monitoring with appropriate FDA-cleared devices can help detect..
Relevance: 30.36858
  • www.empliciti.com
  • 2
EMPLICITI®, the related logo, and Access Support® are registered trademarks of Bristol-Myers Squibb Company. POMALYST®, POMALYST REMS®, and REVLIMID® are registered trademarks of Celgene Corporation, a Bristol Myers Squibb company... EMPLICITI®..
Relevance: 30.36858
  • www.sprycel.com
SPRYCEL®, the SPRYCEL logo, and Access Support® are registered trademarks of Bristol-Myers Squibb Company... SPRYCEL may help to inhibit BCR-ABL. SPRYCEL works by helping to reduce the number of damaged white blood cells in your body. This reduction..
Relevance: 30.263554